Semaglutide is an injectable medication which, when used in combination with diet and exercise, helps with blood sugar control in type 2 diabetics. Semaglutide belongs to a class of medications called glucagon-like peptide-1 (GLP-1) agonists, which mimic the hormone GLP-1 in your body to lower blood sugar IeveIs after you've eaten a meal.
With Semaglutide, you will slowly work your way up to the target dose at which time you will see the most amount of weight loss. This was the case in the clinical trials, where participants had their dose adjusted until they reached 2.5 mg dose if needed. In the phase 3 trial that measured outcomes at 20 weeks, most participants were able to reach the full dose and also lost weight as their dose was increased. They saw additional weight loss over the remaining 48 weeks at the full dose. It is important to keep in mind that weight loss can take time, and you'll see the best results when you are using your medication in combination with a healthy diet and exercise. Sometimes the medication may not work for you, or you may not be able to tolerate the full dose due to side effects in which case your practitioner will provide additional options or change the protocol to better suit your individual needs.
⬥In 2 months- Lose up to 20 pounds. ⬥
⬥In 4-5 months- Lose up to 40 pounds or more! ⬥
⬥ You can repeat this program as many times as you wish!⬥
Glucagon-like peptide 1 (GLP-1) is a hormone that causes huge effects on the regulation of blood sugar by stimulating glucose-dependent insulin secretion.Insulin is a hormone that promotes sugar uptake by the cells, stores sugar as glycogen, promotes the building of fat, and signals the body to build skeletal muscle.
GLP-1 agonists like Semaglutide help to control your blood sugar, but people taking them also tend to lose weight. GLP-1, the key hormone involved, slows down how fast your stomach empties food (called gastric emptying). And in addition to causing your pancreas to release insulin, Semaglutide also blocks a hormone that causes your liver to release sugar (glucagon).Together, these functions can help you feel less hungry, causing you to eat less food and lose more weight.
GLP-1 agonists like Semaglutide help to control your blood sugar, but people taking them also tend to lose weight. GLP-1, the key hormone involved, slows down how fast your stomach empties food (called gastric emptying).
Semaglutide promotes gradual weight loss, reaching maximum efficacy at the 2.5 mg target dose. In clinical trials, participants saw continued weight loss over 48 weeks at the full dose. Optimal results require a combination of medication, a healthy diet, and exercise. Individual responses vary, prompting practitioners to adjust doses based on tolerance and effectiveness
Semaglutide is FDA-approved for obesity, type-2 diabetes, and reducing cardiovascular risks in those with diabetes and heart disease. For chronic conditions, follow healthcare provider guidance. If considering Semaglutide for weight loss without diabetes, await FDA review for long-term safety insights. Study participants in company trials received treatment for approximately 68 weeks.
All patients start on the lowest dose of Semaglutide at 0.25mgs injected subcutaneously into belly fat every week. All patients increase by 0.25mgs every two weeks as tolerated (slower if nauseous).
Yes, itʼs believed that Semaglutide helps curb your appetite. In addition to slowing gastric emptying to make you feel full longer. GLP-1 also plays a direct role in how appetite is regulated
No, Semaglutide is not a type of insulin or a substitute for insulin. Semaglutide does stimulate your pancreas to release insulin when glucose (sugar) is present. Because Semaglutide relies upon your body's own insulin to have this effect, Semaglutide isn't used when your pancreas can't make insulin, such as in patients with type-1 diabetes.
Yes. Semaglutide is considered to be safe and effective when used as indicated. However, safe doesn't mean there aren't risks. Semaglutide also carries a boxed warning about thyroid C-cell tumors occurring in rodents (with unknown risk in humans). Semaglutide shouldn't be used if you or your family have a history of certain thyroid cancers. Semaglutide should not be used in people with type-1 diabetes or a history of pancreatitis. Semaglutide should be used cautiously for people on other blood sugar lowering medications.
YES.Semaglutide is approved by FDA.
Following are some health issues that can occur by using Semaglutide.
Inflammation of your pancreas (pancreatitis).
Changes in vision.
Low blood sugar (hypoglycemia).
Kidney problems (kidney failure).
Serious allergic reactions.
We believe in partnership and patient education so that you’re able to make informed decisions every step of the way.